Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ITERUM THERAPEUTICS PLC

(ITRM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Iterum Therapeutics : ROSEN, A TOP RANKED LAW FIRM, Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important October 4 Deadline in Securities Class Action - ITRM

09/26/2021 | 11:01am EDT

NEW YORK, Sept. 26, 2021 /PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iterum Therapeutics plc (NASDAQ: ITRM) between November 30, 2020 and July 23, 2021, inclusive (the "Class Period"), of the important October 4, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Iterum securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Iterum class action, go to http://www.rosenlegal.com/cases-register-2142.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 4, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the sulopenem New Drug Application ("NDA") lacked sufficient data to support approval for the treatment of adult women with uncomplicated urinary tract infections ("uUTIs") caused by designated susceptible microorganisms proven or strongly suspected to be non-susceptible to a quinolone; (2) accordingly, it was unlikely that the U.S. Food and Drug Administration ("FDA") would approve the sulopenem NDA in its current form; (3) defendants downplayed the severity of issues and deficiencies associated with the sulopenem NDA; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Iterum class action, go to http://www.rosenlegal.com/cases-register-2142.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      cases@rosenlegal.com
      www.rosenlegal.com

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/rosen-a-top-ranked-law-firm-encourages-iterum-therapeutics-plc-investors-with-losses-to-secure-counsel-before-important-october-4-deadline-in-securities-class-action--itrm-301385153.html

SOURCE Rosen Law Firm, P.A.


© PRNewswire 2021
All news about ITERUM THERAPEUTICS PLC
10/01DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit..
BU
10/01ITERUM THERAPEUTICS : Monday Deadline for Investors to Actively Participate in Iterum Ther..
BU
09/29SHAREHOLDER ALERT : Pomerantz Law Firm Reminds Shareholders with Losses on their Investmen..
PR
09/29Top Premarket Gainers
MT
09/28ITERUM THERAPEUTICS : Evaluating Optimal Design for Additional Late-Stage UTI Drug Trial A..
MT
09/28ITERUM THERAPEUTICS : Provides Update from FDA Type A Meeting Regarding Oral Sulopenem
AQ
09/28Iterum Therapeutics Provides Update from FDA Type A Meeting Regarding Oral Sulopenem
CI
09/28ITERUM THERAPEUTICS : to Present Data at IDWeek 2021
AQ
09/27ITERUM THERAPEUTICS PLC (NASDAQ : Itrm) october 4, 2021 investor filing deadline:
PR
09/26ITERUM THERAPEUTICS : ROSEN, A TOP RANKED LAW FIRM, Encourages Iterum Therapeutics plc Inv..
PR
More news
Analyst Recommendations on ITERUM THERAPEUTICS PLC
More recommendations